Home » Newsletters » BioWorld Science

BioWorld Science

July 25, 2011

View Archived Issues

Ajinomoto synthesizes novel IL-12 and/or IL-23 production inhibitors

First two stages complete in phase IIb INO-8875 trial in glaucoma

PET tracer [18F]-SNUBH-NM-333 shows promise in diagnosis of Alzheimer's disease

GlaxoSmithKline histamine H3 receptor antagonist shows moderate activity in Alzheimer's disease

New prostanoid EP2 receptor agonists reported by Japanese company

Celgene discloses novel inhibitors of TNF-alpha production and/or phosphodiesterase 4

Novel agents for schizophrenia disclosed by Takeda

Mochida Pharmaceutical prepares new free fatty acid FFA1 receptor agonists

Sanofi researchers describe new tryptase beta inhibitor prodrugs

Potent PTP-1B-targeted antisense therapy enters phase I trial in type 2 diabetes

Enrollment begins in pilot study of Repligen's RG-1068 to improve detection of pancreatic cancer

EMA's CHMP recommends approval of dexdor

Takeda discloses preclinical data on new small-molecule GSK-3 inhibitor for Alzheimer's disease

ACS-84 evaluated in rat model of Parkinson's disease

Phase I safety data on SAM-760 in healthy young and elderly subjects

Acacia Pharma initiates phase II study of locally administered xerostomia drug

Positive CHMP opinion for Incivo

Janssen Biotech receives FDA complete response letter regarding Simponi

Biotie Therapies begins phase I imaging trial of SYN-120

CHMP makes recommendations following review of pioglitazone-containing medicines

Tarceva recommended for E.U. approval as first-line therapy in distinct type of lung cancer

FDA committee recommends new approval for Remicade

Afinitor recommended for new European approval

CHMP issues opinion on Zytiga in prostate cancer

R-Tech Ueno amends protocol of its phase I trial in eyelash hypotrichosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...